#donanemab — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #donanemab, aggregated by home.social.
-
Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.jp/news/2026/09/21/japan/science-health/alzheimers-day/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
-
Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.jp/news/2026/09/21/japan/science-health/alzheimers-day/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
-
Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.jp/news/2026/09/21/japan/science-health/alzheimers-day/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
-
Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.jp/news/2026/09/21/japan/science-health/alzheimers-day/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
-
Clinical trials for the treatment of Alzheimer's disease continue to face a global shortage of participants despite the arrival of new drugs and treatments, a trend that could slow progress in dementia therapies. https://www.japantimes.co.jp/news/2026/09/21/japan/science-health/alzheimers-day/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
-
https://www.europesays.com/at/406193/ Welt-Alzheimertag: Durchbruch bei der Früherkennung in Graz? – VOL.AT #Alzheimer #AT #Austria #Biomarker #Demenz #Donanemab #Forschung #Früherkennung #Gedächtnis #Gehirn #Gesundheit #Health #Lecanemab #Österreich #Wissenschaft